Applied Pharmacology of the Nervous and Endocrine System Modulators of Neuronal Excitability

Slides from University of Portsmouth about Applied Pharmacology of the Nervous and Endocrine System Modulators of Neuronal Excitability. The Pdf explores drugs acting on voltage-gated ion channels and monoaminergic neurotransmitters, useful for university-level Biology students.

See more

30 Pages

M33319 - Applied Pharmacology of the Nervous and Endocrine System
Modulators of Neuronal Excitability
Ngan Pan Bennett Au, PhD!
Lecturer in Pharmacology (Neuroscience)!
School of Pharmacy and Biomedical Science,!
University of Portsmouth
1
Learning objectives
Identify the various classes of drugs that target axonal voltage-gated ion
channels, and their mechanisms of action in altering neuronal activity.
Identify the various classes of drugs that target monoaminergic
neurotransmitters/receptors/transporters, and their mechanisms of action
in altering neuronal activity.
Identify the appropriate clinical indications for these different drugs.
2

Unlock the full PDF for free

Sign up to get full access to the document and start transforming it with AI.

Preview

UNIVERSITYOF PORTSMOUTH

M33319 - Applied Pharmacology of the Nervous and Endocrine System
Modulators of Neuronal Excitability
Ngan Pan Bennett Au, PhD
Lecturer in Pharmacology (Neuroscience)
School of Pharmacy and Biomedical Science,
University of Portsmouth

Learning Objectives

  • Identify the various classes of drugs that target axonal voltage-gated ion
    channels, and their mechanisms of action in altering neuronal activity.
  • Identify the various classes of drugs that target monoaminergic
    neurotransmitters/receptors/transporters, and their mechanisms of action
    in altering neuronal activity.
  • Identify the appropriate clinical indications for these different drugs.

Drugs Covered in This Lecture

a
Somatodendritic
Axonal
Intracellular recording
Action potentials
Excitatory inputs
Kv4.2
Kv3 throughout dendrite
Proximal
dendrites
Kv2.1
EPSPs
0
-
8
88
Distal
dendrites
PP
888
0
-
8
P
Nodes of Ranvier
Nav, KCNQ. Kv3.1b
HCN
Cav
Inhibitory
inputs
IPSPs
AIS
Nav, KCNQ
Dendritic action potentials
4
Neurotransmitter
release
Dopamine neuron
Noradrenaline neuron
5-Hydroxytryptamine neuron
Tyrosine
Amph.
MPP+
Cocaine
GBR 12935
WIN 35,428
RTI-121
Amph.
L-DOPA
L-DOPA
Cocaine
Nisoxetine
Reboxetine
5-hydroxytryptophan
DA
DA
5-HT
*
d
DA
DA
5-HT
NA
DAT
1
NET
SERT
DA
Adrenergic .
autoreceptors
5-HT
autoreceptors
DA receptors
Adrenergic receptors
5-HT receptors
Drugs targeting axonal
voltage-gated ion channels
Tyrosine
Tryptophan
Amph.
MDMA
Cocaine
Fluoxetine
Paroxetine
Sertraline
Back propagation
Nav, Kv1, Cav
Presynaptic
nerve
terminals
P
Soma
Kv1
IXPs
8
O
8
autoreceptors
Drugs targeting monoaminergic
neurotransmitters

Types of Voltage-Gated Ion Channels

a
Somatodendritic
Axonal
Intracellular recording
Action potentials
Excitatory inputs
Kv4.2
Kv3 throughout dendrite
Proximal
dendrites
Kv2.1
EPSPs
Soma
Kv1
IXPs
0
o
A
Distal
dendrites
8
88
O
=
Nodes of Ranvier
Nav. KCNQ. Kv3.1b
0
HCN
Cav
Inhibitory
inputs
IPSPs
AIS
Nav, KCNQ
O
o
Dendritic action potentials
Back propagation
Neurotransmitter
release
Membrane potential (mv
3 voltage-gated Na+
channel inactivated
(no ion flow)
voltage-gated K+
4 channel opens,
K+ leaves cell
2 voltage-gated Na+
channel opens;
time
Na+ rushes in
resting potential re-established,
Na+ channel closed (not
inactive)
-50
1 voltage-gated Na+
channel
closed
time of stimulation

  • Voltage-gated sodium (Nav) ion channels
  • Voltage-gated potassium (Kv) ion channels
  • Voltage-gated calcium (Cav) ion channels
  • Abundantly expressed in axon initial segment (AIS)
    . Determine the threshold for firing an action potential
  • Action potential propagates along the axon and reach the axonal terminal
  • Activate Cav
  • Calcium influx and neurotransmitter release
    4
    +50
    Nav, Kv1, Cav
    Presynaptic
    nerve
    terminals
    0
    OUNIVERSITYOF
    PORTSMOUTH

Voltage-Gated Sodium Channels

  • 10 different Nav identified in mammals
  • Nav1.1 - Nav1.9 and atypical NavX
  • Based on the difference in a-subunit
  • All are expressed in nervous system, except Nav1.4
  • CNS: Nav1.1 - Nav1.3, Nav1.5, Nav1.6
  • PNS: Nav1.7 - Nav1.9
  • a-subunit (260 kDa): pore-forming
  • 4 homologous transmembrane domain I-IV
  • Each domain has six hydrophobic a-helical transmembrane segments (S1-S6)
  • S4: voltage sensor (change in membrane potential) - related to activation of
    Nav
  • TTX (tetrodotoxin)-sensitive: Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, Nav1.7
  • TTX-resistant: Nav1.5, Nav1.8, Nav1.9
  • 3 intracellular loops
    A
    ₿1/3-subunit
    c-subunit
    ฿ 2/4-subunit
    =
    =
    IV
    NH
    NH
    Voltage
    sensor
    Outside
    C
    C
    wow !!
    1 2345 6
    12 345 6 12345 6
    12345 6
    Inside
    COOH
    COOH
    PY
    motif
    ER-retention
    signals (Na,1.5)
    Endocytic
    motif
    AnkyrinG
    -binding site
    Di-leucine
    motif
    B
    Na
    -
    Pore loops
    1
    5
    4
    2
    13
    IV
    =
    IFM
    + Inactivation gate
    5
    COOH
    NH

Voltage-Gated Sodium Channels: Beta-Subunit

  • ß-subunit (33-36 kDa): auxiliary subunits
  • Contains three major parts:
  • Independent transmembrane domain
  • Small intracellular C-terminal
  • Large intracellular N-terminal
  • 4 subtypes: 31-34
  • Regulate a-subunit (gated kinetics, voltage-dependence,
    localisation)
    Navß isoforms Distribution in neurons
    ß1
    mainly in large or medium (>30 pm) DRG neurons, less in smaller neurons (<25 um)
    ฿ 2
    widely distributed in CNS and PNS neurons, including cerebral and DRG neurons
    ฿ 3
    mainly in small (<25 um) and medium (25-45 um) neurons, less in large (>45 um) neurons
    ฿ 4
    mainly in large neurons, less in medium and small neurons
    A
    ₿1/3-subunit
    c-subunit
    ฿ 2/4-subunit
    =
    =
    IV
    NH
    NH
    Voltage
    sensor
    Outside
    C
    C
    wow !!
    1 2345 6
    12 345 6 12345 6
    12345 6
    Inside
    COOH
    Inactivation
    gate
    COOH
    PY
    motif
    ER-retention
    signals (Na_1.5)
    Endocytic
    motif
    AnkyrinG
    -binding site
    Di-leucine
    motif
    B
    Na
    -
    Pore loops
    1
    5
    4
    2
    13
    IV
    =
    IFM
    + Inactivation gate
    6
    6
    COOH
    NH

Modulators of Voltage-Gated Sodium Channels: Phenytoin

  • Act as a non-specific sodium channel blocker
    . Stabilise the Nay channels that are inactivated
  • Prolong the refractory period of a neuron
  • Blockade of sodium-dependent action potentials depends on:
  • Voltage: Nav inactivated at positive (+30mV) membrane potential
  • Use: ultimately reduce sustained high-frequency firing of action
    potential
  • Time: time required to dissociate from binding of the drug to Nav
    channels
  • Reduce synaptic release of glutamate
    Medical indication
  • Epilepsy/seizures following neurosurgery or severe head injury
    Open
    Inactivated
    Na+
    Na+
    A
    A
    1
    carbamazepine
    phenytoin
    topiramate
    Na+
    lamotrigine
    valproate
    zonisamide
    Control
    Phenytoin
    1
    On
    Off On
    Off
    peak AP
    +35
    -----
    D
    depolarization (Na' influx)
    repolarization (K+ efflux)
    relative
    refractory
    period
    55
    threshold
    ------
    resting
    - 70
    hyperpolar-
    ization
    absolute
    refractory
    period
    Na+
    transmembrane potential (mV)
    time (ms)
    7UNIVERSITYOF
    PORTSMOUTH

Modulators of Voltage-Gated Sodium Channels: Carbamazepine

  • Act as a non-specific sodium channel blocker
  • Also bind to other voltage-gated ion channels (e.g. Cav channels)
  • Stabilise the Nay channels that are inactivated
  • Prolong the refractory period of a neuron
  • Fewer Nay channels to open and prevent the generation of action
    potential
  • Reduce neuronal excitability
    Medical indication
  • Epilepsy
  • Trigeminal Neuralgia (sudden and severe facial pain caused by
    compression of trigeminal nerve)
  • Mania (abnormally elevated arousal and energy level)
    Open
    Inactivated
    Na+
    Na+
    A
    A
    1
    carbamazepine
    phenytoin
    topiramate
    Na+
    Na+
    Carbamazepine
    +35
    ----
    D
    depolarization (Na' influx)
    repolarization (K+ efflux)
    K
    relative
    refractory
    period
    . 55
    threshold
    -------
    resting
    . 70
    --
    hyperpolar-
    ization
    absolute
    refractory
    period
    On
    Off
    lamotrigine
    valproate
    zonisamide
    peak AP
    transmembrane potential (mV)
    time (ms)
    8UNIVERSITYOF
    PORTSMOUTH

Voltage-Gated Calcium Channels

  • Ca2+: second messenger within the cells for regulation of
    many signalling pathways
  • Cav: activate upon membrane depolarisation and
    mediate Ca2+ influx in response to action potentials and
    sub-threshold depolarisation signals.
  • Five subunits:
  • a1: pore-forming subunit; 4 homologous I-IV domain
    (each contains 6 transmembrane helices S1-S6);
    voltage-sensing
  • a28: disulfide-linked glycoprotein dimer; drug target for
    gabapentinoids
  • B: intracellular subunit; stabilise the conformation of a1
  • y: transmembrane glycoprotein subunit
    Ca2+
    a2
    Y
    α1
    Contraction
    Secretion
    Synaptic transmission
    Protein
    phosphorylation
    Enzyme
    regulation
    Nucleus
    1
    XXX
    Gene transcriptionUNIVERSITYOF
    PORTSMOUTH

Types of Voltage-Gated Calcium Channels

  • Five types of Cav:
  • L-type (long-lasting via DHP receptors)
  • N-type (neural; found in brain and PNS)
  • P-type (Purkinje; cerebellum)
  • R-type (residual; cerebellar granule cells and
    neurons)
  • T-type (transient; many neurons, cells with
    pacemaker activity; thalamus)
    Ca2+
    a2
    8
    Y
    α1
    Contraction
    Secretion
    Synaptic transmission
    Protein
    phosphorylation
    Enzyme
    regulation
    Nucleus
    1
    Gene transcriptionTable 1. Subunit composition and function of Ca2+ channel types
    Ca2+ current
    &1
    Subunits
    Specific
    blocker
    Principal physiological functions
    Inherited diseases
    L
    Cav1.1
    DHPs
    Excitation-contraction coupling in
    skeletal muscle, regulation of
    transcription
    Hypokalemic periodic
    paralysis
    Cay1.2
    DHPs
    Excitation-contraction coupling in
    cardiac and smooth muscle,
    endocrine secretion, neuronal
    Ca2+ transients in cell bodies and
    dendrites, regulation of enzyme
    activity, regulation of transcription
    Timothy syndrome: cardiac
    arrhythmia with
    developmental
    abnormalites and autism
    spectrum disorders
    Cav1.3
    DHPs
    Endocrine secretion, cardiac
    pacemaking, neuronal Ca2+
    transients in cell bodies and
    dendrites, auditory transduction
    Cay1.4
    DHPs
    Visual transduction
    Stationary night blindness
    N
    Cav2.1
    @-CTx-GVIA Neurotransmitter release,
    Dendritic Ca2+ transients
    P/Q
    Cav2.2
    @-Agatoxin
    Neurotransmitter release,
    Dendritic Ca2+ transients
    Familial hemiplegic migraine,
    cerebellar ataxia
    R
    Cay2.3
    SNX-482
    Neurotransmitter release,
    Dendritic Ca2+ transients
    T
    Cay3.1
    None
    Cay3.2
    Pacemaking and repetitive firing
    Pacemaking and repetitive firing
    Absence seizures
    Cay3.3
    Abbreviations: DHP, dihydropyridine; @-CTx-GVIA, @-conotoxin GVIA from the cone snail Conus geographus; SNX-482, a
    synthetic version of a peptide toxin from the tarantula Hysterocrates gigas.
    11
    UNIVERSITYOF
    PORTSMOUTH
    type

Modulators of Voltage-Gated Calcium Channels: Ethosuximide

  • Block T-type calcium channels
  • T-type calcium channels are:
  • Low-threshold calcium spikes: appear when neuronal
    membrane potentials are below -69mV
  • Amplitude of depolarisation is ~25mV: raise the membrane
    potential to -40mV
  • Opening of Nav: burst of action potential
  • Burst-firing is observed in rodent models of absence epilepsy
    Medical indications
  • treatment of absence seizures
    A
    Regular firing
    B
    Burst firing
    10 mV
    40 ms
    -55 mV
    -75 mV
    C
    Action potential
    (high-threshold
    Na+ spike)
    D
    Low-threshold
    Ca2+ spike
    10 mV
    40 ms
    10 mV
    T channels
    opening and closing
    -46 mV
    4 ms
    -63 mV
    12UNIVERSITYOF
    PORTSMOUTH

Modulators of Voltage-Gated Calcium Channels: Gabapentin

  • Ligand of a28 calcium channel subunit (modulate a1 functions and stabilize cellular
    localisation of Cav)
  • Bind to a28 and impair its regulatory functions and protein-protein interactions
    with other proteins
  • Block the translocation of Cay towards the cell membrane
  • Lower the amount of functional Cav at presynaptic terminals
  • Reduce neurotransmitter release & neuronal excitability
    Medical indications
  • Epilepsy
  • Neuropathic pain
  • Spasticity (rigid muscles) in multiple sclerosis
    Hyperexcited Neuron
    Presynaptic
    Subunit
    Channel
    Neurotransmitters
    Postsynaptic
    Modulation of Hyperexcited Neuron
    With Pregabalin
    Presynaptic
    Pregabalin
    C2-8
    Subunit
    Ca2+
    Channel
    - --- --
    Neurotransmitters
    Postsynaptic

Can’t find what you’re looking for?

Explore more topics in the Algor library or create your own materials with AI.